Original Articles See more
-
Characterization of acquired nutlin-3 resistant non-small cell lung cancer cells
Published on: 5 Dec 2020 -
Evaluation of the reducing potential of PSMA-containing endosomes by FRET imaging
Published on: 26 Nov 2020 -
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance
Published on: 13 Nov 2020 -
A bendamustine resistance gene signature in diffuse large B-cell lymphoma and multiple myeloma
Published on: 26 Nov 2020
-
EGFR signaling promotes resistance to CHK1 inhibitor prexasertib in triple negative breast cancer
Published on: 5 Dec 2020 -
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance
Published on: 13 Nov 2020
-
MEK inhibition activates STAT signaling to increase breast cancer immunogenicity via MHC-I expression
Published on: 25 Apr 2020
Review Articles See more
-
The role of extracellular vesicles in acquisition of resistance to therapy in glioblastomas
Published on: 13 Nov 2020 -
Cell-mediated and cell membrane-coated nanoparticles for drug delivery and cancer therapy
Published on: 3 Nov 2020
-
Natural products as a means of overcoming cisplatin chemoresistance in bladder cancer
Published on: 5 Dec 2020 -
Key genes and drug delivery systems to improve the efficiency of chemotherapy
Published on: 7 Jan 2021 -
P53-regulated autophagy and its impact on drug resistance and cell fate
Published on: 5 Dec 2020 -
Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
Published on: 5 Dec 2020
Others See more
-
Overcoming drug resistance in glioblastoma: new options in sight?
Editorial|Published on: 13 Jan 2021 -
Application of liquid biopsy for prognostic status of cancers and drug response
Editorial|Published on: 3 Nov 2020 -
Can HIPEC be used against platinum-resistance and for inducing sensitivity to PARP inhibitors in ovarian cancer?
Commentary|Published on: 10 Jul 2020
Most Cited Papers In Last Two Years See more
How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?
-
MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution
Review|Published on: 19 Dec 2019 -
Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors
Review|Published on: 19 Sep 2019
-
Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer
Review|Published on: 19 Dec 2018 -
Cancer drug resistance: a new perspective
Editorial|Published on: 19 Mar 2018 -
Improved potency of F10 relative to 5-fluorouracil in colorectal cancer cells with p53 mutations
Original Article|Published on: 19 Mar 2018
Ongoing Special Issues See more
Special Issue Ebooks See more
About The Journal
-
ISSN
2578-532X (Online)
Publisher
OAE Publishing Inc.
Article Processing Charge
OAE Publishing Inc. undertakes Article Processing Charge for authors
-
Editor-in-Chief
Godefridus J. Peters
Publishing Model
Gold Open Access
Copyright
Copyright is retained by authors
-
Publication Frequency
Quarterly
Contact Us
Journal Data Analysis
Total publications: 196
Total article views: 502,967
Total article downloads: 69,573
Membership
-
COPE
Cancer Drug Resistance is a member of the Committee on Publication Ethics (COPE) and fully adhere to its Code of Conduct and to its Best Practice Guidelines.
-
STM
Cancer Drug Resistance is a member of and subscribes to the principles of STM. Authors of cdr can reuse a certain quantity of article contents from the chargeable publications of other STM members for free in their submissions to cdr.
-
ORCID
Cancer Drug Resistance is a member of ORCID and MESAs system has been connected with ORCID. After submissions to cdr are published, they will be automatically synchronized to the authors' ORCID accounts if the authors have connected their MESAs accounts with ORCID accounts. cdr's reviewers can choose to synchronize their review records to their ORCID accounts when filling in review reports.
-
Crossref
Cancer Drug Resistance is a member of Crossref, which makes research outputs easy to find, cite, link, assess, and reuse.
-
iThenticate
All submissions to Cancer Drug Resistance are checked for plagiarism by iThenticate.
-
Check for updates
All published articles in Cancer Drug Resistance are enriched with a record of the current article status.
Open Archives
-
Portico
All published articles will be preserved here permanently.
https://www.portico.org/